Publication | Open Access
Preliminary safety and antiviral activity of VIR-2218, an X-targeting HBV RNAi therapeutic, in chronic hepatitis B patients
28
Citations
0
References
2020
Year
HepatologyViral HepatitisX-targeting Hbv RnaiAntiviral ActivityImmunologyHepatitis BHepatitisVirologyPreliminary SafetyAntiviral Drug DevelopmentAntiviral TherapyAntiviral ResponseAntiviral DrugMedicine
No additional data available for this publication yet. Check back later!